Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene

Studies in mice lacking genes encoding for substance P or its receptor (NK1), or with NK1 antagonists, have shown that this system contributes to nociception, but the data are complex. Here, we have further examined the role of NK1 receptors in pain and hyperalgesia by comparing nociceptive responses to mechanical and chemical stimulation of viscera and the resulting hyperalgesia and inflammation in NK1 knockout (-/-) and wild-type (+/+) mice. We concentrated on visceral nociception because substance P is expressed by a much greater proportion of visceral than cutaneous afferents. NK1 -/- mice showed normal responses to visceral mechanical stimuli, measured as behavioural responses to intraperitoneal acetylcholine or hypertonic saline or reflex responses to colon distension in anaesthetized mice, although -/- mice failed to encode the intensity of noxious colon distensions. In contrast, NK1 -/- mice showed profound deficits in spontaneous behavioural reactions to an acute visceral chemical stimulus (intracolonic capsaicin) and failed to develop referred hyperalgesia or tissue oedema. However, in an identical procedure, intracolonic mustard oil evoked normal spontaneous behaviour, referred hyperalgesia and oedema in -/- mice. The inflammatory effects of capsaicin were abolished by denervation of the extrinsic innervation of the colon in rats, whereas those of mustard oil were unchanged, showing that intracolonic capsaicin evokes neurogenic inflammation, but mustard oil does not. Tests of other neurogenic inflammatory stimuli in NK1 -/- mice revealed impaired behavioural responses to cyclophosphamide cystitis and no acute reflex responses or primary hyperalgesia to intracolonic acetic acid. We conclude that NK1 receptors have an essential role mediating central nociceptive and peripheral inflammatory responses to noxious stimuli that evoke neurogenic inflammation, and modulating responses to noxious mechanical stimuli. We propose that two separate hyperalgesia pathways exist, one of which is NK1 receptor dependent, whereas the other does not require intact substance P/NK1 signalling.

[1]  A. Saria,et al.  Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues , 1983, Journal of Neuroscience Methods.

[2]  S. Boyce,et al.  Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils , 1996, PAIN.

[3]  A. Stabentheiner,et al.  Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. , 1993, European journal of pharmacology.

[4]  A. Dickenson,et al.  The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord , 1993, Neuroscience Letters.

[5]  S. Harrison,et al.  Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. , 1994, European journal of pharmacology.

[6]  M. Millan,et al.  Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent , 1995, Pain.

[7]  P. Mantyh,et al.  Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. , 1997, Science.

[8]  S. Hunt,et al.  Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo. , 1998, Journal of the autonomic nervous system.

[9]  C. Gardner,et al.  The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. , 1997, General pharmacology.

[10]  K. McCarson,et al.  Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons , 1999, Neuroscience.

[11]  H. Schaible,et al.  Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. , 1995, Journal of neurophysiology.

[12]  L. Buéno,et al.  Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats. , 1994, Gastroenterology.

[13]  C. Epstein,et al.  Primary afferent tachykinins are required to experience moderate to intense pain , 1998, Nature.

[14]  M. Palkovits,et al.  Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Cerveró Sensory innervation of the viscera: peripheral basis of visceral pain. , 1994, Physiological reviews.

[16]  J. Longhurst,et al.  Role of spinal NK1 receptors in cardiovascular responses to chemical stimulation of the gallbladder. , 1995, The American journal of physiology.

[17]  J. Laird,et al.  Cyclophosphamide cystitis in mice: Behavioural characterisation and correlation with bladder inflammation , 1999, European journal of pain.

[18]  J. Besson,et al.  Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States , 1999, The Journal of Neuroscience.

[19]  R. Traub The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat , 1996, PAIN.

[20]  W. Willis,et al.  Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. , 1994, Journal of neurophysiology.

[21]  S. Lawson,et al.  Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves , 1998, Neuroscience.

[22]  A. Basbaum,et al.  Morphological characterization of substance P receptor‐immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis , 1995, The Journal of comparative neurology.

[23]  T. Ness,et al.  Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat , 1988, Brain Research.

[24]  P. Laduron,et al.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Jänig,et al.  Afferent and sympathetic neurons projecting into lumbar visceral nerves of the male rat , 1991, The Journal of comparative neurology.

[26]  C. Maggi,et al.  The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles , 1998, Neuropeptides.

[27]  P. Mantyh,et al.  Transmission of chronic nociception by spinal neurons expressing the substance P receptor. , 1999, Science.

[28]  K. Westlund,et al.  Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation , 1997, British journal of pharmacology.

[29]  Q. Ma,et al.  Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. , 1995, The Journal of physiology.

[30]  P. Mclean,et al.  Effects of tachykinin receptor antagonists on the rat jejunal distension pain response. , 1998, European journal of pharmacology.

[31]  P. Rivière,et al.  Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat. , 1994, European journal of pharmacology.

[32]  C. Maggi,et al.  NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: Demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207 , 1992, Neuroscience Letters.

[33]  M. Maccoss,et al.  In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. , 1997, European journal of pharmacology.

[34]  James N. Campbell,et al.  Peripheral and central mechanisms of cutaneous hyperalgesia , 1992, Progress in Neurobiology.

[35]  E. Torebjörk,et al.  Novel classes of responsive and unresponsive C nociceptors in human skin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  T. Doubell,et al.  Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons , 1996, Nature.

[37]  S. Raja,et al.  Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. , 1999, Anesthesiology.

[38]  C. Maggi,et al.  Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. , 1992, Journal of the autonomic nervous system.

[39]  C. Woolf,et al.  Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. , 1997, European journal of pharmacology.

[40]  M. Giamberardino,et al.  Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia , 1995, Pain.

[41]  Stephen P. Hunt,et al.  Altered nociception, analgesia and aggression in mice lacking the receptor for substance P , 1998, Nature.